|
US2020179421A1
|
|
Methods and compositions for preventing and treating conditions related to alpha-synuclein
|
|
US2018369261A1
|
|
Use of N-acetylglucosamine and derivatives thereof to treat muscle disorders
|
|
CA3008722A1
|
|
Excipient free glucosamine tablets and method of making
|
|
US2014161867A1
|
|
Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
|
|
CA2556343A1
|
|
Synthetic nutritional formulations
|
|
US2005268915A1
|
|
Nasal adaptation of an oral inhaler device
|
|
CA2414500A1
|
|
Agonist-aversive combination medicines
|
|
CA2408023A1
|
|
Glucosamine as a food and beverage additive
|
|
CA2384922A1
|
|
Topical glycopyrrolate product for the reduction of sweating
|
